{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:51:28Z","timestamp":1792245088243,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hypothalamic-pituitary axis dysfunction is a common complication in post-operative craniopharyngioma(CP) patients, and it greatly impacts the long-term quality of life of such patients. To better understand the effects of postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement therapy in patients with childhood CP, we assessed approximately 200 patients with childhood-onset CP postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical details of patients with childhood-onset CP who underwent sellar tumor resection in Beijing Children\u2019s Hospital and Beijing Tiantan Hospital from 2018 to 2019 were retrieved retrospectively. The participants were followed up to assess the effects of post-operative long-term hormone replacement therapy and assess the tumor recurrence rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age of admission was 8.1 (1.8, 14.3) years. Headache (45.5%), visual impairment (39.5%), and nausea (33.0%) were the most common clinical manifestations. ACP accounted for 95% of all CP cases. The incidence of central adrenal insufficiency and central hypothyroidism within the first week after surgery was 56.2% and 70.3%, respectively. At the same time 85.5% of the patients required at least one dose of desmopressin to control urine output. Total survival and tumor recurrence rates were 98.6% and 26.1%, respectively, with a median follow-up time of 29.7 (19.0, 40.3) months. During the follow-up period, 28.1% patients met the diagnostic criteria for short stature, while 54.4% fit the criteria for obesity. In addition, 94.4% of the patients were taking at least one kind of hormone substitution, and 74.7% were taking three or more. The prevalence of levothyroxine, glucocorticoid, desmopressin, and growth hormone replacement therapy was 87.3%, 77.5%, 78.9% and 31.0%, respectively. The proportion of patients treated with the substitutive combination of levothyroxine, hydrocortisone, and desmopressin was 54.9%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is a large-sample systematic postoperative endocrine function evaluation of patients with childhood-onset CP. Due to the high prevalence of post-operative hypothalamic-pituitary dysfunction, patients with CP usually require long-term multiple hormone substitution therapy. Individualized management and accurate hormone replacement dosage for postoperative childhood-onset CP patients are of great importance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1241145","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T11:01:55Z","timestamp":1699268515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma"],"prefix":"10.3389","volume":"14","author":[{"given":"Yuqi","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin N.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11102-012-0418-4","article-title":"Pathology and pathogenesis of craniopharyngiomas","volume":"16","author":"Larkin","year":"2013","journal-title":"Pituitary"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01127-6","article-title":"Descriptive epidemiology of craniopharyngiomas in the United States","volume":"24","author":"Momin","year":"2021","journal-title":"Pituitary"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04750-z","article-title":"Adamantinomatous craniopharyngioma: advances in proteomic research","volume":"37","author":"Desiderio","year":"2021","journal-title":"Childs Nerv Syst"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations","volume":"161","author":"Sekine","year":"2002","journal-title":"Am J Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2019.0321","article-title":"The postopera tive quality of life in children and adolescents with craniopharyngioma","volume":"116","author":"Eveslage","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"Zacharia","year":"2012","journal-title":"Neuro Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.4.0547","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"89","author":"Bunin","year":"1998","journal-title":"J Neurosurg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000113019","article-title":"Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up","volume":"69","author":"Muller","year":"2008","journal-title":"Horm Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2817","article-title":"Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients","volume":"97","author":"Gautier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00381-019-04349-z","article-title":"Excision of pediatric craniopharyngioma: pattern of recurrence in 35 patients at a tertiary care hospital in Saudi Arabia","volume":"36","author":"Al Shail","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1001-2346.2017.1","article-title":"Outcomes of microsurgical resection of recurrent craniopharyngiomas in children","volume":"33","author":"Zhou","year":"2017","journal-title":"Chin J Neurosurgery."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2152656720964158","DOI":"10.1177\/2152656720964158","article-title":"Gross total versus subtotal surgical resection in the management of craniopharyngiomas","volume":"11","author":"Grewal","year":"2020","journal-title":"Allergy Rhinol (Providence)."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyx570","article-title":"Adult craniopharyngioma: case series, systematic review, and meta-analysis","volume":"83","author":"Dandurand","year":"2018","journal-title":"Neurosurgery"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0265-y","article-title":"Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma","volume":"101","author":"Sughrue","year":"2011","journal-title":"J Neurooncol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3171\/2020.11.PEDS20803","article-title":"Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity","volume":"28","author":"Ravindra","year":"2021","journal-title":"J Neurosurg Pediatr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2018.02.034","article-title":"Clinical study on microsurgical treatment for craniopharyngioma in a single consecutive institutional series of 335 patients","volume":"167","author":"Guo","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.wneu.2017.09.164","article-title":"Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: A meta-analysis","volume":"109","author":"Alotaibi","year":"2018","journal-title":"World Neurosurg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2018.549","article-title":"Craniopharyngioma - clinical and therapeutic outcome data in A mixed cohort of adult and paediatric cases","volume":"14","author":"Capatina","year":"2018","journal-title":"Acta Endocrinol (Buchar)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000507702","article-title":"Prevalence of endocrine and metabolic comorbidities in a national cohort of patients with craniopharyngioma","volume":"93","author":"Jazbin\u0161ek","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.2004.0","article-title":"Changes of hypothalamus-pituitary hormones in patients after total removal of craniopharyngiomas","volume":"117","author":"Zhou","year":"2004","journal-title":"Chin Med J (Engl)."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4103\/1793-5482.151502","article-title":"Endoscopic endonasal trans-sphenoid management of craniopharyngiomas","volume":"10","author":"Yadav","year":"2015","journal-title":"Asian J Neurosurg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/jns.2002.97.1.0003","article-title":"Craniopharyngioma in adults and children: a study of 122 surgical cases","volume":"97","author":"Van Effenterre","year":"2002","journal-title":"J Neurosurg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/a-0641-5956","article-title":"Childhood craniopharyngioma: A 22-year challenging follow-up in a single center","volume":"50","author":"Tosta-Hernandez","year":"2018","journal-title":"Horm Metab Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0449","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy","volume":"161","author":"Holmer","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0993","article-title":"Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma","volume":"95","author":"Holmer","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1241145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T11:02:00Z","timestamp":1699268520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1241145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":34,"alternative-id":["10.3389\/fendo.2023.1241145"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1241145","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"article-number":"1241145"}}